Schedule 13D ownership disclosure
Amneal Pharmaceuticals Inc
Security class unavailable · CUSIP: 03168L105
Event date: 2019-06-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 21,300,504
- Percent of class
- 14.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-19-001162
- Form type
- SC 13D
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Sep 11, 2019
- Reporting period
- Jun 10, 2019
- Description
- Schedule 13D beneficial ownership